Elyse Gellerman

Elyse Gellerman serves as the Chief Executive Officer at Neuroendocrine Tumor Research Foundation. With a background in healthcare management and consulting, Elyse has held various executive positions in oncology services and business development at organizations such as HCA/Sarah Cannon Cancer Services and Aspen Healthcare Metrics. Elyse is skilled in strategic planning, clinical margin management, and market analysis, with a focus on driving growth and development in the healthcare industry. Elyse holds a MHS in Healthcare Systems and a Certificate in Healthcare Marketing from the University of Denver, as well as a BA in American History from Cornell University.